Tag: TIGIT immunotherapy
iTeos ESMO Data: Promising Win for TIGIT in Nasdaq (ITOS)
iTeos Therapeutics (NASDAQ:ITOS) has been making significant strides in the field of immunotherapy, focusing on a molecule targeting TIGIT, a checkpoint with a complex...